InsidersTradesSigma
Unicycive Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4)
Explore the full management transaction log of Unicycive Therapeutics, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Unicycive Therapeutics, Inc. has published 9 insider filings. Market capitalisation: €220m. The latest transaction was reported on 26 August 2025 (C). Among the most active insiders: Aggarwal Gaurav. The full history is free.
9
Insider Decl.
0
Thresholds
€11,855
1 ops.
Buy Volume
·
0 ops.
Sell Volume
29Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 26 August 2025
Declarations9 total
652,900 sharesCommon StockSEC:0001213900-25-080808:0
1,400,000 sharesCommon StockSEC:0001213900-25-015152:0
5,500,000 sharesCommon StockSEC:0001213900-24-086928:0
3,470,152 sharesCommon StockSEC:0001213900-23-056885:0
104,612 sharesCommon StockSEC:0001213900-23-056875:0
104,612 sharesCommon StockSEC:0001213900-23-056848:0
41,845 sharesCommon StockSEC:0001213900-23-056864:0
26,738 shares0Common StockSEC:0001213900-22-052329:0
15,000 shares@ US$0.8250.0054% mcap100.0% of flowCommon StockSEC:0001213900-22-027501:0
Ideal exit: 10 Feb 2023 (T+270)
9 of 9 declarations